Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Oxford Finance
AddedFeb 13, 2024
UpdatedJun 28, 2026
Oxford Finance

Oxford Finance

Operating

Oxford Finance LLC: Global provider of financial solutions, specializing in healthcare and life sciences sectors.

Location
Alexandria, VA, US
Founded
2002
Firm
Compare
Portfolio
Employees
Website

Oxford Finance LLC specializes in providing financial solutions to the healthcare and life sciences sectors. The firm offers a range of credit facilities, typically ranging from $10 million to $150 million, catering to companies at various stages of growth. Oxford Finance has a global reach, serving clients worldwide with a focus on debt financing, post-IPO debt, and other tailored financial services.

Notable portfolio companies include Adma Biologics, Agile Therapeutics, AliveCor, and Castle Biosciences. Oxford Finance prides itself on deep industry expertise and long-standing relationships within its focus sectors. The firm's investment philosophy emphasizes flexibility and service, aiming to support the growth and success of its borrowers. Key partners and decision-makers are not specifically mentioned, but the firm's reputation is built on its comprehensive understanding of the healthcare and life sciences industries.

Oxford Finance - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments91
Current Portfolio Count72
Total Portfolio Exits8

Top Investment Stages

Debt Financing52 (59.8%)
Post Ipo Debt24 (27.6%)
Public4 (4.6%)
Series B4 (4.6%)
Series Unknown3 (3.4%)

Stage Mix

Debt Financing 60%Post Ipo Debt 28%Public 5%Series B 5%Series Unknown 3%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Headspace logo

Headspace

Amino logo

Amino

Pearl Street Dental Partners logo

Pearl Street Dental Partners

Renibus Therapeutics logo

Renibus Therapeutics

Antheia logo

Antheia

Selux Diagnostics logo

Selux Diagnostics

Verastem logo

Verastem

Lexicon Pharmaceuticals logo

Lexicon Pharmaceuticals

Choice Health at Home logo

Choice Health at Home

Kezar Life Sciences logo

Kezar Life Sciences

Viracta Therapeutics logo

Viracta Therapeutics

Platelet BioGenesis logo

Platelet BioGenesis

Nature's Fynd logo

Nature's Fynd

RxSight logo

RxSight

Vedanta Biosciences logo

Vedanta Biosciences

Enable Injections logo

Enable Injections

Selecta Biosciences logo

Selecta Biosciences

Epic Healthcare Staffing logo

Epic Healthcare Staffing

Syros Pharmaceuticals logo

Syros Pharmaceuticals

Genapsys logo

Genapsys

Equillium logo

Equillium

Xeris Biopharma Holdings logo

Xeris Biopharma Holdings

Talphera logo

Talphera

RefleXion Medical logo

RefleXion Medical

Summit Healthcare Reit logo

Summit Healthcare Reit

Oxford Finance - Similar Investment Firms

Oxford Bioscience Partners logo

Oxford Bioscience Partners

kilbycream.com

Oxford Capital Partners logo

Oxford Capital Partners

oxcp.com

Oxford Square Capital logo

Oxford Square Capital

ticc.com

Oxeon Partners logo

Oxeon Partners

oxeon.com

Oxford Sciences Innovation logo

Oxford Sciences Innovation

oxfordsciences.com

BroadOak Capital Partners logo

BroadOak Capital Partners

Orix Venture Finance logo

Orix Venture Finance

Blue Ox Healthcare Partners logo

Blue Ox Healthcare Partners

blueoxhcp.com

Oxford Lane Capital logo

Oxford Lane Capital

Oxford Technology Management logo

Oxford Technology Management

Oxantium Ventures logo

Oxantium Ventures

oxantium.com

640 Oxford logo

640 Oxford

640oxford.com

Focus Capital Partners logo

Focus Capital Partners

Octagon Capital Advisors logo

Octagon Capital Advisors

Partners for Growth logo

Partners for Growth

pfgrowth.com

Oxford Finance - Classification

Also Known As
  • Oxford Finance LLC
NAICS
  • 520000Finance and Insurance
SIC
  • 6000Depository Institutions
ISIC
  • 6630Fund management activities
Show 11 more industry codes
NAICS
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523940Portfolio Management and Investment Advice
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6200Security And Commodity Brokers, Dealers, Exchanges, And Services
  • 6700Holding And Other Investment Offices
  • 6280Services Allied With The Exchange Of Securities Or Commodities
  • 6720Investment Offices
  • 6282Investment Advice
  • 6722Management Investment Offices, Open-end